Introduction: Itraconazole (I) is an important therapeutic agent in the management of serious fungal infections, though adequate serum concentrations are necessary for clinical success. Bioavailability of itraconazole in capsule form has been problematic and can be reduced as much as 50% in AIDS patients with gastric hypoacidity. Itraconazole oral solution (IOS) has improved bioavailability when compared to the capsule formulation and unlike capsules, itraconazole oral solution absorption may not be acid-dependent. Objective: To determine the effect of omeprazole, an acid-suppressing proton pump inhibitor, on peak serum concentrations (Cmax) of itraconazole oral solution. Methods: We performed an open label, prospective, randomized, crossover study in healthy adult volunteers. Fifteen subjects each received 400 mg itraconazole oral solution after an overnight fast on 2 occasions, with at least a 7 day washout period between doses. Subjects were randomized to receive 40 mg omeprazole nightly for 7 days prior to either itraconazole oral solution dose 1 or 2. Serum samples were obtained prior to itraconazole oral solution dose, and then at 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, and 8 hours post-dose. Concentrations of itraconazole and hydroxyitraconazole, an active metabolite, were determined by HPLC. Results: Interim analysis of 9 subjects indicates that omeprazole significantly decreased the Cmax of itraconazole (mean 1.80 vs. 1.29 5g/mL, median difference between treatments =0.238 5g/mL, p<0.01, Wilcoxon Signed Rank). Cmax of hydroxyitraconazole (1.03 vs. 0.98 5g/mL, median difference=0.032 5g/mL, p=0.65) and time to Cmax (Tmax) for both itraconazole and hydroxyitraconazole were not significantly different between treatments (p=0.14,p=0.24, Wilcoxon Signed Rank). Conclusions: Our preliminary data suggest that concurrent administration of omeprazole, a potent gastric acid suppressor, reduces the peak serum concentrations of itraconazole oral. Significance: Our data suggests that caution should be taken when administering omeprazole and itraconazole oral solution concurrently. In addition, adequate absorption of itraconazole oral solution in persons with documented gastric hypoacidity remains to be demonstrated. Therefore, documentation of adequate serum itraconazole concentrations may be important to achieving therapeutic success in those with compromised gastric acidity. Future Plans: We plan to complete the study in the remaining two patients who have already enrolled, and then analyze HPLC results for all 17 patients. Results of this study will be submitted for publication in a peer-review journal in 1999.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
3M01RR000030-39S4
Application #
6425022
Study Section
Project Start
1999-12-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
39
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Barroso, Julie; Leserman, Jane; Harmon, James L et al. (2015) Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage 50:69-79
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32

Showing the most recent 10 out of 128 publications